Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cutis|August 1, 1996
Progressive hemifacial atrophy: ten-year observation of a caseJ Urban, B Toruniowa, M ChibowskaMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 21, 2001
Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patientsM Chibowska, D Krasowska, J WeglarzPrzeglad Dermatologiczny|March 1, 1990
[Changes in various apolipoprotein levels in psoriasis]B Toruniowa, M Chibowska, A PietrzakAnnales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina|January 1, 1990
[Clinical, histopathologic, immunofluorescent and ultrastructural estimation of 2 cases of epidermolysis bullosa acquisita]B Lecewicz-Toruń, M Chibowska, D Chibowski, et al.Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): electrocardiographic substudy--three months follow-upR Paulisiński, M Chibowska, A Biłan, et al.Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatmentS Ostrowski, M Chibowska, A Biłan, et al.Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): echocardiographic substudy--three months follow-upA Biłan, M Chibowska, B Makaruk, et al.Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): ECG exercise testing--three months follow-upA Biłan, M Chibowska, R Palusiński, et al.Przeglad Dermatologiczny|July 1, 1990
[Studies of the role of cellular immunity and angiogenetic changes in the pathogenesis of circumscribed scleroderma]S Majewski, M Błaszczyk, M Chibowska, et al.Pageof 1